Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

T2D.com vs Ways2Well

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

6.1

T2D.com

Best for diabetic GLP-1 access

Starting at $999/mo

CompoundedSemaglutideTirzepatidePrescriber Included
Visit T2D.com
7.1

Ways2Well

Best for patients wanting required-labs structure rather than questionnaire-only intake

Starting at $219/mo

CompoundedSemaglutideTirzepatideRequired labs
Visit Ways2Well

Side-by-Side Comparison

FeatureT2D.comWays2Well
Overall Score6.1/107.1/10
Starting Price$999/mo$219/mo
Customer Rating
Features7 features5 features
States Available150
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

T2D.com

Pros

  • Built specifically for type 2 diabetic and pre-diabetic patients
  • Integrated service — prescriber, pharmacy, and delivery handled in one flow
  • Offers both compounded semaglutide and compounded tirzepatide
  • Temperature-controlled home delivery via UPS or FedEx
  • Ongoing prescriber monitoring and support included

Cons

  • No pricing published on the public website — must register to see costs
  • No states list published on the site
  • Newer brand with limited independent reviews
  • Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro

Ways2Well

Pros

  • Required labwork enforces baseline monitoring
  • Both semaglutide and tirzepatide available
  • Clinician supervision through intake and follow-up

Cons

  • Pricing higher than aggressive compounded competitors
  • 3.0★ Trustpilot score lower than peers — review independent feedback before committing

Our Verdict

Winner: Ways2WellScore: 7.1/10

Ways2Well edges out T2D.com with a higher overall score of 7.1/10 and is particularly strong for patients wanting required-labs structure rather than questionnaire-only intake. T2D.com remains a solid alternative, especially if you're looking for diabetic GLP-1 access.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.